People say these peptides hurt them. Their stories are muffled in MAHA’s push for medical freedom

Key Points:

• Dylan Meetze experienced severe side effects, including fatigue, anxiety, and muscle twitching, after using the unapproved peptide drug BPC-157, which is popularized for wellness and body optimization but lacks FDA approval or clinical trials.
• Use of BPC-157 is rising in the U.S., driven by online influencers like Stanford neuroscientist Andrew Huberman, despite warnings that these peptides are experimental and not intended for human consumption.
• The U.S. Department of Health and Human Services, led by Secretary Robert F. Kennedy Jr., is pushing to ease restrictions on experimental peptides, appointing industry-linked doctors to FDA advisory panels that recently voted to allow compounding pharmacies to produce these drugs for human use without FDA approval.
• FDA scientists and medical experts caution that insufficient evidence exists to prove the safety or efficacy of these peptides, warning of potential risks such as liver damage, allergic reactions, and delayed identification of harmful effects like cancer.
• Patients and users report mixed experiences online, with some suffering serious adverse effects and others touting benefits, while critics argue that the lack of rigorous clinical trials and regulatory oversight puts public health at risk and diminishes incentives for proper research.